Variants of the Interleukin-10 Promoter Gene Are Associated With Obesity and Insulin Resistance but Not Type 2 Diabetes in Caucasian Italian Subjects
- Daniela Scarpelli1,
- Marina Cardellini2,
- Francesco Andreozzi1,
- Emanuela Laratta1,
- Marta Letizia Hribal1,
- Maria Adelaide Marini2,
- Vittorio Tassi3,
- Renato Lauro2,
- Francesco Perticone1 and
- Giorgio Sesti1
- 1Department of Experimental and Clinical Medicine, University Magna Grjcia of Catanzaro, Catanzaro, Italy
- 2Department of Internal Medicine, University of Rome-Tor Vergata, Rome, Italy
- 3Unità di Diabetologia ed Endocrinologia, Istituto di Ricovero e Cura a Carattere Scientifico-Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
- Address correspondence and reprint requests to Giorgio Sesti, MD, Dipartimento di Medicina Sperimentale e Clinica, Policlinico Mater Domini, Via Tommaso Campanella 88100, Catanzaro, Italy. E-mail: sesti{at}unicz.it
Abstract
Interleukin (IL)-10 is a major anti-inflammatory cytokine that has been associated with obesity and type 2 diabetes. The three polymorphisms −1082G/A, −819C/T, and −592C/A in the IL10 promoter were reported to influence IL10 transcription. We investigated whether these polymorphisms were associated with type 2 diabetes and related traits in a cohort of Italian Caucasians comprising 551 type 2 diabetic and 1,131 control subjects. The −819C/T and −592C/A polymorphisms were in perfect linkage disequilibrium (r2 = 1.0). The −1082G/A polymorphism was not associated with type 2 diabetes or related traits. Although the −592C/A polymorphism was not associated with type 2 diabetes, nondiabetic homozygous carriers of the A allele showed increased BMI and insulin resistance and lower plasma IL-10 levels compared with the other genotypes. In the nondiabetic group, the ATA haplotype was associated with an increased risk for obesity (odds ratio 1.28 [95% CI 1.02–1.60]; P = 0.02). The ATA/ATA composite genotype was associated with an increased risk for obesity (1.96 [1.16–3.31]; P = 0.01) and insulin resistance (1.99 [1.12–3.53]; P = 0.01). This study suggests that polymorphisms and haplotypes of the IL10 promoter may be associated with obesity and insulin resistance in a large sample of Italian Caucasians.
Footnotes
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted February 16, 2006.
- Received January 11, 2006.
- DIABETES
